Today: 2 March 2026
Subscribe
Browse Category

Mergers & Acquisitions 19 December 2025 - 21 December 2025

Warner Bros. Discovery (WBD) Stock Week Ahead: Netflix Deal vs. Paramount Tender Offer Keeps Shares in “Merger-Arbitrage Mode”

Warner Bros. Discovery (WBD) Stock Week Ahead: Netflix Deal vs. Paramount Tender Offer Keeps Shares in “Merger-Arbitrage Mode”

Warner Bros. Discovery shares closed Friday at $27.77, nearly matching Netflix’s $27.75-per-share offer but below Paramount Skydance’s $30 all-cash bid. Trading volume surged ahead of a holiday-shortened week, with thin liquidity expected as markets close early for Christmas. The stock’s price reflects uncertainty between the two competing takeover paths. WBD’s market cap stands at about $68.5 billion.
21 December 2025
···
Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce closed Friday, Dec. 19, at $259.91, down about 21.75% year-to-date. The company finalized its Informatica acquisition and reported Agentforce and Data 360 annual recurring revenue near $1.4 billion, up 114% from last year. Investors are watching AI adoption and M&A integration as holiday trading thins liquidity.
21 December 2025
···
BioMarin (BMRN) Stock Jumps on $4.8 Billion Amicus Deal: Latest News, Forecasts and Analyst Outlook for Dec. 21, 2025

BioMarin (BMRN) Stock Jumps on $4.8 Billion Amicus Deal: Latest News, Forecasts and Analyst Outlook for Dec. 21, 2025

BioMarin shares jumped 17.7% to $61.15 on December 19 after announcing a $4.8 billion all-cash deal to acquire Amicus Therapeutics for $14.50 per share, a 33% premium. Trading volume hit 18.5 million shares. The acquisition, expected to close in Q2 2026, adds two marketed rare-disease drugs and a late-stage asset to BioMarin’s portfolio.
21 December 2025
···
Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

BioMarin Pharmaceutical will acquire Amicus Therapeutics for $14.50 per share in cash, valuing the deal at about $4.8 billion. Amicus stock closed at $14.18 on December 19, up 30% in a day and near the offer price. The deal is expected to close in Q2 2026, pending regulatory and shareholder approval. Amicus resolved key Galafold patent litigation ahead of the announcement.
21 December 2025
···
Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

President Trump and nine major drugmakers announced deals on Dec. 19 to cut Medicaid and cash-pay drug prices, shifting U.S. pharma policy focus. Shares of most participating firms rose 1%–3%. Trading in the week of Dec. 22–26 is expected to be volatile due to thin holiday liquidity and headline sensitivity. U.S. markets will close early Dec. 24 and remain shut Dec. 25.
21 December 2025
·········
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

BioMarin Pharmaceutical will acquire Amicus Therapeutics for $14.50 per share in cash, valuing the deal at about $4.8 billion. Amicus shares closed at $14.18 on December 19, reflecting a small merger spread tied to regulatory and deal-closing risks. Both boards approved the agreement. Closing is targeted for Q2 2026, pending shareholder and antitrust approvals.
20 December 2025
···
ServiceNow (NOW) Stock News on Dec. 20, 2025: Armis Deal Rumors, 5-for-1 Split, Analyst Targets and the 2026 Outlook

ServiceNow (NOW) Stock News on Dec. 20, 2025: Armis Deal Rumors, 5-for-1 Split, Analyst Targets and the 2026 Outlook

ServiceNow shares closed at $155.31 on Friday, up 1.26% after a volatile week driven by reports of advanced talks to acquire cybersecurity firm Armis for up to $7 billion. Trading volume surged to 25.1 million shares, far above recent averages. The stock remains about 35% below its 52-week high following a mid-December selloff tied to the possible deal.
20 December 2025
···
Tether-Linked Buyers Close $200 Million Peak Mining Deal as Rumble Pursues $767 Million Northern Data Takeover

Tether-Linked Buyers Close $200 Million Peak Mining Deal as Rumble Pursues $767 Million Northern Data Takeover

U.S. regulatory filings show Peak Mining, Northern Data’s bitcoin-mining business, was sold for up to $200 million to Highland Group Mining Inc., Appalachian Energy LLC, and 2750418 Alberta ULC. The deal structure includes $50 million upfront and up to $150 million in deferred profit share. Buyer identities and terms emerged through SEC documents tied to Rumble’s planned acquisition of Northern Data.
20 December 2025
····
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin shares jumped 17.7% to $61.15 Friday after announcing a $4.8 billion all-cash deal to acquire Amicus Therapeutics at $14.50 per share. The acquisition adds two marketed rare-disease drugs and a Phase 3 asset, and resolves U.S. patent litigation over Galafold, delaying generic entry to 2037. BioMarin expects the deal to close in Q2 2026 and be accretive to earnings within a year.
20 December 2025
····
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics in an all-cash deal valued at about $4.8 billion, offering $14.50 per share. Amicus stock jumped roughly 30% to $14.18 on heavy volume, trading just below the bid as investors assess deal closure risks. Both boards approved the transaction, with closing targeted for Q2 2026 pending shareholder and regulatory approvals.
20 December 2025
·····
DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

Trump Media & Technology Group announced an all-stock merger with nuclear fusion firm TAE Technologies, valuing the deal at over $6 billion. DJT shares surged more than 40% on Dec. 18, trading around $16 amid high volatility. The combined company will split ownership evenly between shareholders and target a utility-scale fusion plant. Trump Media CEO Devin Nunes and TAE’s Michl Binderbauer will serve as co-CEOs.
20 December 2025
··
Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media & Technology Group and TAE Technologies announced a $6 billion all-stock merger on Dec. 18, aiming to build a utility-scale fusion power plant by 2026. DJT shares surged 42% on Dec. 18 and another 8% on Dec. 19, closing at $16.09 on heavy volume. Ownership of the combined company is expected to split roughly 50/50, with Trump Media committing up to $300 million in cash support.
20 December 2025
···
Warner Bros. Discovery stock today: Netflix deal vs Paramount $30 bid, analyst forecasts, and what’s next — Dec. 20, 2025

Warner Bros. Discovery stock today: Netflix deal vs Paramount $30 bid, analyst forecasts, and what’s next — Dec. 20, 2025

Warner Bros. Discovery shares traded near $27.77, just above Netflix’s $27.75-per-share takeover offer and below Paramount Skydance’s $30 all-cash bid. The stock’s price reflects market uncertainty over which deal, if any, will close. WBD’s board rejected Paramount’s offer, calling it “illusory.” Both bids claim full financing.
20 December 2025
····
Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

BioMarin Pharmaceutical announced a $14.50-per-share all-cash deal to acquire Amicus Therapeutics, valuing the company at about $4.8 billion. Amicus shares jumped 30% to $14.18 following the news, trading just below the offer price. The deal is expected to close in the second quarter of 2026, pending regulatory and shareholder approval.
20 December 2025
··
Amicus Therapeutics (FOLD) Stock After Hours Dec. 19, 2025: BioMarin’s $14.50 Cash Buyout and What to Know Before the Next Market Open

Amicus Therapeutics (FOLD) Stock After Hours Dec. 19, 2025: BioMarin’s $14.50 Cash Buyout and What to Know Before the Next Market Open

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing the deal at about $4.8 billion. Amicus stock jumped roughly 30% Friday, closing near $14.18. Both boards approved the transaction, expected to close in Q2 2026. The offer is not subject to financing conditions.
20 December 2025
··
SPX Technologies (SPXC) Stock News Today: Crawford United Deal, 2025 Guidance Raise, and Fresh Analyst Forecasts (Dec. 19, 2025)

SPX Technologies (SPXC) Stock News Today: Crawford United Deal, 2025 Guidance Raise, and Fresh Analyst Forecasts (Dec. 19, 2025)

SPX Technologies shares closed near $203 on Dec. 19, 2025, down for the day but up 46.9% over the past year. The company agreed to acquire Crawford United’s commercial air-handling segment for $300 million, expanding its HVAC business. The deal is expected to close in Q1 2026. SPXC plans to sell off Crawford’s industrial and transportation products segment.
19 December 2025
·
ABM Industries (ABM) Stock Slides After Earnings: Record 2025 Revenue, WGNSTAR Acquisition, Dividend Hike and 2026 Forecasts (Dec. 19, 2025)

ABM Industries (ABM) Stock Slides After Earnings: Record 2025 Revenue, WGNSTAR Acquisition, Dividend Hike and 2026 Forecasts (Dec. 19, 2025)

ABM shares fell 3.9% to $41.78 Friday after reporting record Q4 revenue of $2.3 billion but missing earnings estimates with adjusted EPS of $0.88. The company announced a $275 million deal to acquire WGNSTAR and raised its dividend by 9%. Analysts grew cautious, citing margin and leverage concerns. Shares had briefly risen after the earnings release before turning lower.
19 December 2025
··
Caterpillar Stock (NYSE: CAT) Today: AI-Linked Rally Faces a Reality Check as Analysts Lift Targets and RPMGlobal Deal Advances

Caterpillar Stock (NYSE: CAT) Today: AI-Linked Rally Faces a Reality Check as Analysts Lift Targets and RPMGlobal Deal Advances

Caterpillar shares rose 1.9% to $576.56 Friday after a 9.6% five-day drop, the steepest since April. RPMGlobal shareholders approved Caterpillar’s planned acquisition, with 99.88% voting in favor. Australia’s competition regulator cleared the deal on Thursday. Implementation is targeted for February 18, 2026, pending final approvals.
19 December 2025
···
ServiceNow (NOW) Stock Today: Post-Split Trading, Armis Deal Talk, Analyst Targets, and What Wall Street Is Watching on Dec. 19, 2025

ServiceNow (NOW) Stock Today: Post-Split Trading, Armis Deal Talk, Analyst Targets, and What Wall Street Is Watching on Dec. 19, 2025

ServiceNow shares traded around $155 on Dec. 19 after a 5-for-1 stock split took effect this week. The stock saw sharp swings amid reports ServiceNow is in advanced talks to acquire cybersecurity firm Armis for up to $7 billion. Trading volume spiked, and options contracts were adjusted to reflect the split. The broader tech sector also rallied Friday during “triple witching” options expiration.
19 December 2025
··
DJT Stock News Today: Trump Media Shares Jump Again on Dec. 19 as $6 Billion TAE Fusion Merger Sparks Fresh Volatility

DJT Stock News Today: Trump Media Shares Jump Again on Dec. 19 as $6 Billion TAE Fusion Merger Sparks Fresh Volatility

Trump Media & Technology Group shares jumped 8.7% to $16.16 by midday Friday after announcing a $6 billion all-stock merger with nuclear fusion firm TAE Technologies. Trading volume hit 48.2 million shares. The deal would split ownership evenly and target a mid-2026 close, with Devin Nunes and Michl Binderbauer as co-CEOs. Trump Media committed up to $300 million in cash to TAE as part of the agreement.
19 December 2025
··
1 2 3 4 5 6 … 20
Go toTop